Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • May 02, 2019 2:15 PM | Anonymous

    April 2, 2019. MedPage Today

    Quitting smoking significantly reduced the risk of bladder cancer development in postmenopausal women, with the largest risk reduction occurring in the first decade after smoking cessation, researchers reported. 

    Read more.

  • April 30, 2019 9:35 AM | Anonymous

    April 30, 2019, News Medical 

    Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists. The study, published in BMJ Open, found that urine testing was just as good as the cervical smear at picking up high-risk human papillomavirus (HPV), the virus that causes cervical cancer. 

    Read more.

  • April 29, 2019 10:02 AM | Anonymous

    April 29, 2019, MedPage Today OB/GYN Update  

    Pregnant people should continue to be screened for asymptomatic bacteriuria via urine culture, the U.S. Preventive Services Task Force (USPSTF) said.

    Screening for and treating asymptomatic bacteriuria in pregnancy has moderate net benefit in reducing perinatal complications (B recommendation), which is a change from the 2008 A recommendation.

    Read more. 
  • April 29, 2019 9:52 AM | Anonymous

    April 29, 2019, HealthDay News via WebMD 

    Antibiotics can be lifesaving, but using them over a long period might raise the odds of heart disease and stroke in older women, a new study suggests. Researchers tracked the health of nearly 36,500 U.S. women over an average follow-up of nearly eight years. During that time, more than a thousand developed heart disease. The study found that women aged 60 and older who used antibiotics for two months or longer were 32% percent more likely to develop heart disease than those who did not use antibiotics.  

    Read more.

  • April 29, 2019 9:48 AM | Anonymous

    April 29, 2019, Medical News Bulletin 

    Small cell carcinoma accounts for about 0.1% of ovarian cancer cases with reported long-term survival rates of 33% when the disease is diagnosed at an early stage. Of these, about two-thirds of women with small cell carcinoma of the ovaries have hypercalcemia (SCCOHT — small cell carcinoma of the ovary, hypercalcemic type). Researchers discovered that inhibition of certain enzymes called cyclin-dependent kinases 4 and 6 (CDK4/6) blocked the growth of SCCOHT cancer cells.  

    Read more.

  • April 26, 2019 9:09 AM | Anonymous

    April 26, 2019, Medscape 

    Six factors are associated with the eventual development of invasive breast cancer after an initial diagnosis of ductal carcinoma in situ (DCIS), an often benign condition, according to a new Dutch meta-analysis.

    Read more.

  • April 25, 2019 9:33 AM | Anonymous

    April 24, 2019, HemOnc Today  

    Screening with 3-D digital breast tomosynthesis appeared associated with increases in both specificity and proportion of breast cancers detected with better prognosis than two-dimensional digital mammography, according to results of a retrospective observational study published in JAMA Oncology. The findings were especially true for a subgroup of women age 40 to 49.  

    Read more.

  • April 24, 2019 8:38 AM | Anonymous

    April 24, 2019, HealthDay News 

    A type of cervical cancer that's less sensitive to Pap testing is increasing among white women in the United States, new research shows. An overall decline in cervical cancer rates in recent decades has been driven by decreases in squamous cell carcinomas. Most of the rest of cervical cancer cases are adenocarcinomas, which are less likely to be detected by Pap testing and are mainly caused by the human papillomavirus (HPV).

    Read more.

  • April 24, 2019 8:32 AM | Anonymous

    April 24, 2019, Medgadget 

    Preeclampsia is one of the most common serious maladies that pregnant women encounter. It is a poorly understood condition with symptoms such as high blood pressure, proteinuria, and headaches, potentially even leading to seizures. The treatment options for preeclampsia are still very limited, mostly confined to hypertension medications, bed rest, and birthing the baby, which is essentially a cure for the disease. A new option has just been given Breakthrough Device Designation by the U.S. Food and Drug Administration. 

    Read more.

  • April 22, 2019 9:55 AM | Anonymous

    April 22, 2019, Medical News Today 

    Leucine, an amino acid that the body needs for making protein, appears to have a surprising role in the development of resistance to tamoxifen in breast cancer that tests positive for the estrogen receptor. Scientists from Harvard Medical School recently made this "unexpected" discovery about estrogen receptor-positive breast cancer in a study conducted with colleagues from other research centers. 

    Read more.

Powered by Wild Apricot Membership Software